Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

32.97
+0.16230.49%
Post-market: 32.96-0.0050-0.02%16:10 EDT
Volume:1K
Turnover:35.22K
Market Cap:13.19M
PE:- -
High:32.98
Open:32.98
Low:32.96
Close:32.80
52wk High:34.86
52wk Low:25.79
Shares:400.00K
Float Shares:400.00K
Volume Ratio:0.45
T/O Rate:0.27%
Dividend:0.08
Dividend Rate:0.25%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Apollo in Advanced Talks to Acquire Johnson \u0026 Johnson's Orthopedics Unit in Deal Valued Near $20B

Stock News
·
10 hours ago

Edwards Lifesciences CVP, TAVR Daniel J. Lippis Disposes of 619 Common Shares Worth $54,168.69

Reuters
·
14 hours ago

J&J Orthopedics Unit Draws Apollo Interest in Potential $20 Billion Deal, Bloomberg News Reports

Reuters
·
15 hours ago

Apollo Global is Said in Talks to Acquire J&J’s Orthopedics Unit - Bloomberg News

THOMSON REUTERS
·
15 hours ago

Scholar Rock announces FDA approval of isembyld

TIPRANKS
·
15 hours ago

US FDA Approves Scholar Rock's Muscle Weakness Drug

Reuters
·
16 hours ago

Edwards Lifesciences Corp. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
17 hours ago

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

Dow Jones
·
17 hours ago

IntegraGen receives rival takeover bids amid court‑ordered restructuring

TIPRANKS
·
19 hours ago

Pharming wins FDA nod to extend Joenja use to younger APDS children

TIPRANKS
·
19 hours ago

DBS Keeps Their Buy Rating on Merck & Company (MRK)

TIPRANKS
·
21 hours ago

Tylenol Maker, Pharmacy Chains Urge US Appeals Court to Revisit Decision over Alleged Autism Link

Reuters
·
21 hours ago

Berenberg Lifts Price Target on Merck to $137 From $127, Keeps Hold Rating

MT Newswires Live
·
Yesterday

Edwards Lifesciences Price Target Maintained with a $110.00/Share by BTIG

Dow Jones
·
Yesterday

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Labcorp Holdings (LH) and Edwards Lifesciences (EW)

TIPRANKS
·
Yesterday

Edwards Lifesciences Reaffirms 2026 Guidance Following Medicare TAVR Decision

MT Newswires Live
·
Yesterday

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)

TIPRANKS
·
Yesterday

Shenyang Xingqi Gains Nod for Eye Drop Candidate Clinical Study

Stock News
·
Yesterday

The Race for the Next Big Weight-Loss Drug is On-and China Wants In

Dow Jones
·
Yesterday

Edwards Lifesciences comments on TAVR national coverage decision

TIPRANKS
·
Yesterday